Arcturus Therapeutics is developing a vaccine for COVID-19 which is expected to begin human dosing this summer. CEO Joe Payne talks to Cheddar’s Brad Smith about early trials.
SCIENCE
Arcturus CEO Joe Payne Talks Coronavirus Vaccine
Arcturus Therapeutics is developing a vaccine for COVID-19 which is expected to begin human dosing this summer. CEO Joe Payne talks to Cheddar’s Brad Smith about early trials.